ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Revasc®:Sanofi-Aventis (Suisse) SA
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
B01AE01 - DesirudinATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B01 - Antithrombotic Agents
 
B01A - Antithrombotic Agents
 
B01AE - Direct Thrombin Inhibitors
 

The DDD for dabigatran etexilate is based on treatment of patients with NVAF (nonvalvular atrial fibrillation).

B01AE01 - Desirudin
DoseRoute of administrationNote
 P 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home